MBX BIOSCIENCES INC Share Price Today: Live Updates & Key Insights

MBX BIOSCIENCES INC share price today is $28.68, up 0.88%. The stock opened at $28.27 against the previous close of $28.43, with an intraday high of $29 and low of $27.58.

MBX BIOSCIENCES INC Share Price Chart

MBX BIOSCIENCES INC

us-stock
To Invest in {{usstockname}}
us-stock

MBX BIOSCIENCES INC Share Price Performance

$28.68 0.0088(0.88%) MBX at 23 Mar 2026 02:13 PM Biotechnology
Lowest Today 27.58
Highest Today 29
Today’s Open 28.27
Prev. Close 28.43
52 Week High 44.89
52 Week Low 4.81
Day’s Range: Low 27.58 High 29
52-Week Range: Low 4.81 High 44.89
1 day return -
1 Week return -3.79
1 month return -22.06
3 month return -17.63
6 month return +43.14
1 year return +251.53
3 year return -
5 year return -
10 year return -

MBX BIOSCIENCES INC Institutional Holdings

MBX BIOSCIENCES INC Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

MBX BIOSCIENCES INC Fundamentals

Market Cap 1362.59 M

PB Ratio 3.6583

PE Ratio 0.0

Enterprise Value 977.61 M

Total Assets 385.14 M

Volume 670776

MBX BIOSCIENCES INC Company Financials

About MBX BIOSCIENCES INC & investment objective

Company Information MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is Canvuparatide (MBX 2109), a parathyroid hormone peptide prodrug, which is in Phase 3 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing Imapextide (MBX 1416), a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 2 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Organisation Biotechnology

Employees 63

Industry Biotechnology

CEO Mr. Peter Kent Hawryluk MBA

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

MBX BIOSCIENCES INC FAQs

What is the share price of MBX BIOSCIENCES INC today?

The current share price of MBX BIOSCIENCES INC is $28.68.

Can I buy MBX BIOSCIENCES INC shares in India?

Yes, Indian investors can buy MBX BIOSCIENCES INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy MBX BIOSCIENCES INC shares in India?

You can easily invest in MBX BIOSCIENCES INC shares from India by:

Can I buy fractional shares of MBX BIOSCIENCES INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of MBX BIOSCIENCES INC?

MBX BIOSCIENCES INC has a market cap of $1362.59 M.

In which sector does MBX BIOSCIENCES INC belong?

MBX BIOSCIENCES INC operates in the Biotechnology sector.

What documents are required to invest in MBX BIOSCIENCES INC stocks?

To invest, you typically need:

What is the PE and PB ratio of MBX BIOSCIENCES INC?

The PE ratio of MBX BIOSCIENCES INC is N/A and the PB ratio is 3.66.